No Photo Available

Last Update

2016-01-11T00:00:00.000Z

This profile was last updated on .

Is this you? Claim your profile.

Wrong Yaniv Bejerano?

Mr. Yaniv Bejerano

Chief Executive Officer

ImmuneXcite Inc

Direct Phone: (781) ***-****       

Get ZoomInfo Grow

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

ImmuneXcite Inc

3 Forbes Road

Lexington, Massachusetts 02421

United States

Company Description

ImmuneXcite is a privately held biotech company based in Lexington, Mass., that is developing the next generation of immune-activating anti-tumor biotherapeutics against a wide range of cancers using a fundamentally novel immunotherapy platform. The compa ... more

Find other employees at this company (14)

Background Information

Employment History

Contributor

Line56.com

Product Manager

Biosense

Education

B.Sc.

Technion

B.Sc.

Computer Science

Technion - Israel Institute of Technology

MBA

MBA with distinction

Northeastern University

Web References (26 Total References)


Board of Directors - ImmuneXcite : ImmuneXcite

immunexcite.com [cached]

Yaniv Bejerano, CEO

...
Yaniv Bejerano, B.Sc., MBA, CEO Yaniv Bejerano is a Co-Founder of ImmuneXcite and serves as its President and Chief Executive Officer. He has been instrumental in shaping the vision of ImmuneXcite and leading the venture from inception to its current position. Prior to ImmuneXcite, Yaniv held various product management, marketing and business development positions, the latest as Senior Director of Worldwide Product Marketing and Business Development at Enigma. Prior to that, at Biosense, he was a Product Manager leading a product from pre-clinical development through preclinical studies, clinical trials, and 510k submission to the FDA. Biosense was acquired by J&J for $400M. Yaniv holds an MBA from Northeastern University with distinction, and a B.Sc. from the Technion - Israel Institute of Technology.


Leadership Team - ImmuneXcite : ImmuneXcite

immunexcite.com [cached]

Yaniv Bejerano, CEO

...
Yaniv Bejerano, B.Sc., MBA Co-Founder and Chief Executive Officer Yaniv Bejerano is a Co-Founder of ImmuneXcite and serves as its President and Chief Executive Officer. He has been instrumental in shaping the vision of ImmuneXcite and leading the venture from inception to its current position. Prior to ImmuneXcite, Yaniv held various product management, marketing and business development positions, the latest as Senior Director of Worldwide Product Marketing and Business Development at Enigma. Prior to that, at Biosense, he was a Product Manager leading a product from pre-clinical development through preclinical studies, clinical trials, and 510k submission to the FDA. Biosense was acquired by J&J for $400M. Yaniv holds an MBA from Northeastern University with distinction, and a B.Sc. from the Technion - Israel Institute of Technology.


ImmuneXcite Presents New Preclinical Data at AACR Demonstrating Ability of its Novel Cancer Immunotherapy Approach to Activate a Potent and Precise T-Cell Attack on Tumors - ImmuneXcite : ImmuneXcite

immunexcite.com [cached]

"ImmuneXcite's approach has the potential to generate precise and potent therapies for patients with a range of solid tumors who currently have no or limited treatment options," said Yaniv Bejerano, ImmuneXcite Chief Executive Officer and Co-Founder.


The Biotech Boom: What We Can Learn From a Banner Year ยป Oxbridge Biotech Roundtable

www.oxbridgebiotech.com [cached]

Yaniv Bejerano, ImmuneXcite, Inc.


Recent Events - ImmuneXcite : ImmuneXcite

immunexcite.com [cached]

Yaniv Bejerano, Co-Founder and CEO, ImmuneXcite, Inc., presented on the company's novel immunotherapy platform technology. The title of his presentation was "mAbXcite: A novel immunotherapy platform that initiates a robust anti-cancer immune response by recruiting and activating neutrophils".

Similar Profiles

Other People with this Name

Other people with the name Bejerano

Andrea Bejerano
Zerto Inc

Mariana Bejerano
Jersey City Public Schools

Michael Bejerano
Continental Mechanical

Brian Bejerano
Seafood City Supermarket

Inbar Bejerano
AlgoSec Inc

City Directory Icon

Browse ZoomInfo's Business Contact Directory by City

People Directory Icon

Browse ZoomInfo's
Business People Directory

Company Directory Icon

Browse ZoomInfo's
Advanced Company Directory